Ranolazine for Improving Symptoms of Palpitations

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT01495520

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 4
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT01495520
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT01495520. Randomized; triple masking; primary purpose treatment. Start 2014-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Ranolazine for Improving Symptoms of Palpitations
Acronym
RYPPLE
Condition
Ischemic Heart Disease
Intervention (Drug)
Ranolazine
Intervention (Drug)
Placebo
Lead sponsor
University of Roma La Sapienza (class: other)

Record details

Record id
cardio:ct-nct01495520
Content hash
6df76917b84f9589142bb9c4ad0c93925f992e4a2dc06c0149acc06394c4566c